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doi:10.1016/j.ejvs.2010.02.001Abstract Introduction: Recent developments in aortic stent-graft technology have led to an
increase in the use of wholly percutaneous endovascular aneurysm repair (P-EVAR). The liter-
ature was systematically reviewed to analyse the results of P-EVAR.
Methods: A systematic review of P-EVAR was performed using Ovid-MEDLINE in-process and
other nonindexed citations and Ovid-MEDLINE and EMBASE (January 1991eJuly 2009). Primary
outcomes reviewed were success rate and loco-regional complications. Secondary outcomes
included; operative time, hospital stay, time to ambulation, blood loss and cost. Prospective
randomised and controlled nonrandomised studies were included as were case series (retro-
spective and prospective). Case reports, letters, review articles and non-English language arti-
cles were excluded.
Results: Twenty-two papers were identified. These included randomised trials (nZ 1);
prospective nonrandomised (nZ 10) and retrospective studies (nZ 11). P-EVAR was at-
tempted in 1087 patients (1751 groins). Overall success rate of percutaneous arterial closure
was 92% (90.1e93.9, 95% CI). Access related complication rate was 4.4% (3.5e5.3, 95% CI).
Seven studies provided data on access related complications in open access cohorts (O-EVAR).
In these studies, P-EVAR was associated with fewer access related complications (RR 0 .47, 95%
CI 0.28e0.78, pZ 0.004). P-EVAR was associated with reduced operative time.
Conclusion: P-EVAR appears safe and effective in selected patients. Local access related
complications were low. Further work is required to identify the most suitable candidates
for P-EVAR.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Vascular Institute, 4th Floor, St James Wing, St George’s Healthcare NHS Trust, Blackshaw Road,
252816; fax: þ44 2087253495.
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Endovascular aortic aneurysm repair (EVAR) is an attractive
minimally invasive technique for the repair of infra-renal
abdominal aortic aneurysms (AAA) with low operative
morbidity and mortality. However, local groin wound
complications as a result of exposure of the common
femoral arteries are not insignificant1e13 (Table 1).
This has led some surgeons to develop alternative access
techniques. Larzon described a minimal access suture
technique of the cribriform fascia ‘fascial closure’,
however, complication rates are significant and the tech-
nique has not been widely adopted.14,15 Early attempts
with a wholly P-EVAR approach proved disappointing.16
However, recent advances in stent-graft technology with
a reduction of stent-graft delivery profile have led to
a resurgence in the interest in P-EVAR.
Perclose ProstarXL (Abbott) is the main device available
for percutaneous closure of large bore arterial access
sheaths. Although the ProstarXL is the only device with
formal approval for use in EVAR, several authors have used
the Proglide system (Abbott) off-label.17,18 The percuta-
neous closure device is usually deployed prior to access
sheath placement in what is described in the literature as
the ‘‘Preclose Technique’’. Several modifications to this
technique have been reported. Briefly, a small stab incision
through the skin is made caudal to the anticipated arterial
puncture site (common femoral artery). Some authors
advocate blunt dissection to facilitate sheath passage
which should be in an oblique manor. Micropuncture angi-
ography or ultrasound is recommended to confirm correct
puncture site. The initial sheath is replaced with the
percutaneous closure device over a wire. The needles are
deployed and sutures secured to avoid slippage and
entanglement. Some centres use two Prostar devices for
the main delivery system. The endovascular procedure is
performed as usual. At the end of the procedure, the
sheath is removed slowly (usually over a wire as a safety
net) while a knot is tied with the aid of a knot pusher. TheTable 1 Wound complications in EVAR-open femoral
access.
Study Local wound
complication rate
Blum et al.13 (nZ 154) 4%
Stelter et al.12 (nZ 201) 5%
Brewster et al.11 (nZ 30) 14%
May et al.10 (nZ 108) 4%
Trehane et al.9 (nZ 49) 18%
Chuter et al.8 (nZ 50) a26%
Moore et al.7 (nZ 100) 5%
Cohnert et al.6 (nZ 37) 14%
Faries et al.5 (nZ 368) 8%
Slappy et al.4 (nZ 77) 2%
Kibbe et al.3 (nZ 235) 3%
Dalainas et al.2 (nZ 186) a20%
Birch et al.1 (nZ 99) 16%
a Individual complications added up to obtain the overall
complication rate.skin is closed by a single suture or adhesive tape. Local
variations in the techniques exist.19,20
This review analyses the evidence to support the use of
P-EVAR over standard aortic stent-graft delivery through
open arterial exposure in the groin.
Methods
A systematic review of P-EVAR was performed from January
1991 to July 2009 using Ovid-MEDLINE in-process and other
nonindexed citations and Ovid-MEDLINE and EMBASE. The
following search strategy was used (Fig. 1); aortic aneu-
rysm mapped to search heading (Aortic Aneurysm,
Abdominal/or Aneurysm, Dissecting/or Aneurysm,
Ruptured/or Aneurysm/or Aneurysm, Infected/or Aortic
Aneurysm, Thoracic/or Aneurysm, False/or Aortic Aneu-
rysm) the search result was combined with the term
percutaneous. Prospective and retrospective studies and
those with a control group (standard open groin exposure)
were included but case reports, letters, review articles and
non-English language articles were excluded. Manual
review of the systematic search result was performed to
retrieve relevant titles and data was extracted indepen-
dently by two authors (AM, RH).
Primary outcome was success rate of percutaneous
closure (defined as closure of the common femoral artery
without the need of open surgical dissection). Secondary
outcomes assessed were operative duration, hospital stay,
time to ambulation, blood loss, cost and late loco-regional
complications defined as any event that led to delayed
healing, additional intervention or follow up. Study
outcome heterogeneity was analysed by means of the Chi-
squared test. Means were weighted and data pooled after
significant study outcome heterogeneity was excluded and
confidence intervals were provided if enough data was
available. Data on success rate and complication rates were
analysed using Fisher’s exact test. A p-value less than 0.05
was considered as significant. Statistical analysis was per-
formed using SPSS 16.0 (SPSS, Chicago, IL).
Results
The initial systematic search retrieved (311 articles, 258 for
EMBASE). Limits were applied to work in English and
involving humans (252 articles). 219 Titles remained after
excluding review articles and case reports. Manual review
of the retrieved titles and abstracts after exclusion of
duplicate and irrelevant publications resulted in a total of
22 titles. These included a randomised trial (nZ 1);
prospective nonrandomised studies (nZ 8) and retrospec-
tive studies (nZ 13) (Fig. 1). One study (Lee, 2007)21was
excluded from pooling as it appeared that a later study17
potentially shared a proportion of the patient population.
Success rate of percutaneous closure
The 22 retrieved papers reported on the success rate of
percutaneous closure (Table 2). The overall reported
success rate of percutaneous closure (SR) was 92% (90.1e
93.9, 95% CI). The rate of totally percutaneous closure
(where percutaneous closure was attempted and successful
Figure 1 Systematic search strategy.
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studies16,18,22e32; 79% (74.9e83.1, 95% CI).
Factors potentially influencing success rate
Patient and device selection
One study randomised patients suitable for EVAR into stan-
dard open femoral access versus percutaneous closure.29 P-
EVAR was offered to a series of consecutive patients in 13
studies.28,16e19,21,24e26,30,33e35 Patient selection wasn’t clear
in 8 studies20,22,23,27,31,32,36,37 (Table 3).
Patients with thoracic aortic pathology were included in
eight studies. Seven studies excluded heavy femoral artery
calcification.16,18,24,25,28,32,35 The next most commonTable 2 P-EVAR success rate.
Author Year n Study type Success
rate (%)
Heyer et al.22 2009 14 Retrospective 96
Arthurs et al.19 2008 88 Retrospective 95
McDonnell et al.33 2008 17 Prospective 71
Jean-Baptiste et al.24 2008 19 Prospective 92
Najjar et al.23 2007 11 Retrospective 96
Lee et al.17 2008 292 Retrospective 94
Lee et al.21 2007 183 Retrospective 94
Dosluoglu et al.18 2007 17 Prospective 90
Watelet et al.25 2006 29 Prospective 83
Starnes et al.26 2006 49 Retrospective 94
Peterson et al.27 2005 7 Retrospective 100
Quinn et al.20 2004 63 Retrospective 100
Morasch et al.34 2004 47 Prospective 93
Borner et al.28 2004 95 Prospective 89
Torsello et al.29 2003 15 RCT 96
Rachel et al.36 2002 62 Prospective 76
Howell et al.30 2002 30 Prospective 96
Quinn31 2002 15 Prospective 93
Howell et al.35 2001 144 Prospective 94
Teh et al.32 2001 44 Retrospective 85
Traul et al.16 2000 17 Retrospective 65
Haas et al.37 1999 12 Retrospective 100exclusion criterion was scarred groins in five
studies.24,25,32,33,35 Patients with femoral artery aneurysms
were excluded in three studies26,29,32 (Table 3).
There was no statistically significant difference in the
percutaneous closure success rate in the studies that
considered all comers17,19,29,30,34 and the studies that
excluded patients with femoral artery calcification and
groin scarring.24e26,32,35 (94%, 92.3e95.7, 95% CI versus
91%, 88.2e93.8, 95% CI, p> 0.5)
The majority of studies (nZ 19) used the ProstarXL.
Three studies from two groups dealt with Proglide. The
success rate in the Proglide group, 93.7% (91.5e95.9, 95%
CI) was better than in the Prostar group 90% (88.4e91.6,
95% CI) PZ 0.02. The complication rates in the Proglide
group were 1.9% (1.5e4.3%, 95% CI) versus 4.8% (3.3e6/3%,
95% CI) for the Prostar group PZ 0.03.
Sheath size
Details on percutaneous closure success rate according to
sheath size were available in 10 studies (Table 4). There
was a tendency of success rate to decrease with increasing
sheath size. Three studies reported a statistically signifi-
cant difference in success rate with increasing sheath
size.21,26,36 Sheath size was considered a reason for failure
in 6 studies16,18,25,26,28,36 and a cause of complications in
three studies.21,25,29
Scarred groins
Previous groin surgery was a reason for P-EVAR exclusion in
four studies.24,25,32,33
Despite attempting to exclude patients with scarred
groins, failure was attributed to patients with scarred
groins in one study.32 Another study involving a significant
proportion of patients with previous catheterisation and
scarring found no correlation with failure.36
Obesity
Obesity was associated with P-EVAR failure in five
studies.21,26,29,32,35 However, in only one was this rela-
tionship statistically significant.35 One study found no
correlation of failure with obesity.36
Table 3 Patient selection.
Author Patient selection Exclusion criteria
Consecutive/
all comers
Randomised Unclear Calcification Occlusive dis. Scarred Groin Femoral
Aneurysm
Heyer et al.22 X
Arthurs et al.19 X X
McDonnell et al.33 X X
Jean-Baptiste et al.24 X X X
Najjar et al.23 X
Lee et al.17 X
Lee et al.21 X
Dosluoglu et al.18 X X
Watelet et al.25 X X X
Starnes et al.26 X X
Peterson et al.27 X
Quinn et al.20 X
Morasch et al.34 X
Borner et al.28 X X
Torsello et al.29 X X
Rachel et al.36 X
Howell et al.30 X
Quinn et al.31 X
Howell et al.35 X X X
Teh et al.32 X X X X
Traul et al.16 X X
Haas et al.37 X
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The overall access related complication in reviewed studies
of P-EVAR was 4.4% (3.5e5.3, 95% CI). Seven papers
compared data on access related complications withTable 4 Success rate and sheath size.
Author Sheath size Success rate
Arthurs et al.19 <20F 97%
>20F 80%
Lee et al.17 <16F 99%
>16F 93%
Lee et al.21 a 12-6F 99%
18-24F 91% p< 0.01
Doslouglu et al.18 12-16F 93%
18-22F 88%
Watelet et al.25 22-24F 79%
16F 89%
Starnes et al.26 a 18F 99%
20F 78% p< 0.05
Borner et al.28 14F 93%
16F 97%
18F 100%
20F 80%
Rachel et al.36 a 16F 85%
22F 64% p< 0.05
Howell et al.30 22 &16 F 93%
Traul et al.16 16F 73%
>22F 57%
a Difference reported as significant.a control cohort of patients undergoing standard open groin
arterial exposure.21,23,24,29,33,34,36 Study heterogeneity was
not significant and pooled data suggested P-EVAR was
associated with less access related complications, relative
risk 0.47 (0.28e0.78, 95% CI), pZ 0.004.
Three studies associated an increase in access related
complication rate in P-EVAR with sheath size.21,26,29 One
showed a significant association of complications with large
sheath size and obesity.26
Hospital stay
Hospital stay was reported in seven studies.18,24,26,30,31,33,34
Mean hospital stay was 2.07 days. The difference in
hospital stay between P-EVAR and EVAR was assessed in
three studies. In all three studies, hospital stay was shorter
in patients undergoing P-EVAR. P-EVAR was associated with
a shorter hospital stay (2.7 vs. 3.5 days weighted
mean).24,33,34 One study reported a significant
difference.24
Operative time
Eight studies reviewed operative time.16,21,24,28e30,34,36
P-EVAR was associated with less operative time compared
to open groin exposure (106 vs. 145 min, weighted mean).
Operative time was reported as significantly shorter in five
out of the eight studies.16,29,30,34,36 Compared to EVAR,
a significant proportion of P-EVAR procedures was per-
formed under local anaesthesia as reported in two
studies.24,34
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One study reported significantly less blood loss in P-EVAR
compared to O-EVAR.30 Although blood loss in P-EVAR and
O-EVAR was similar, failed P-EVAR resulted in more blood
loss.28,34 The randomised controlled study reported similar
blood loss in all three groups (P-EVAR, O-EVAR and failed
P-EVAR).29
Time to ambulation and cost
Ambulation time was reported in three studies. One study
reported ambulation in 81% of patients 4e6 h following P-
EVAR.20 Ambulation time was shorter for P-EVAR in
comparison with O-EVAR.29,34
One study reported less cost associated with P-EVAR, but
this was statistically non significant.24 P-EVAR average
procedure cost was V99 more than O-EVAR group in the
randomised study.7 Another study reported an overall
increase in procedural cost despite a shorter operative time
due to the cost of closure devices (US $295 per closure
device).21 Neither study explored the effect of reduced
hospital stay on overall cost.
Discussion
The result of this systematic review of the evidence on
percutaneous endovascular aneurysm repair was based on
the available published studies. Mostly retrospective or
prospective nonrandomised studies, with only one rando-
mised controlled trial. This should be considered when
interpreting results. Interestingly, the review results are
close in many respects to this single centre RCT.29 Issues of
selection bias should be considered, however it was
possible to perform P-EVAR with good results in randomised
and non selective patients (calcified arteries, scarred groins
and obesity).
In this systematic review, P-EVAR was shown to be both,
a feasible and safe alternative to open femoral access. The
overall success rate was high even in an unselected pop-
ulation.29 Several studies included ruptured aneurysms,
which may be a particularly attractive indication due to the
feasibility to perform under local anaesthesia in unstable
patients.23,28
Vessel calcification, obesity and scarred groins were
considered a contributory factor in failure in several
studies. This should not be a deterrent to P-EVAR in this
group of patients as it is these patients who would benefit
the most from a wholly percutaneous approach. Keeping
this in mind, data suggests that surgeons need to proceed
with caution in performing P-EVAR in obese patients with
small calcified vessels. Despite this, there is a need to
identify more clearly patients who are at risk of developing
complications.
Other outcomes measured were also in favour of P-EVAR.
The overall access related complication rate in the all the
included titles was low and comparable to the best results
in O-EVAR series (Table 1). The incidence of access related
complication rate was significantly higher in O-EVAR in the
cohort that reported complications in both P-EVAR and
O-EVAR groups in the same study.21,23,24,29,33,34,36The two widely available percutaneous closure devices
are the Perclose ProstarXL and the Perclose Proglide
(Abbott). Three studies from two research groups used the
Proglide17,18,21 with the remaining studies reporting on
the ProstarXL. Authors experienced with the Proglide
report ease of manipulation and knot tying attributed to
device design and the use of monofilament sutures in
contrast to the braided sutures in the ProsrarXL.17,18 In
coronary interventions the braided sutures have been
more prone to infection.38 The overall rate of infection
remains low in P-EVAR. Difficulties in suture manipulation
were initially reported as a reason for failure and
conversion were more commonly seen with the Prostar
device.16,18,25 The review results indicate a higher
complication rate using the ProstarXL. However, these
results should be interpreted with caution because of the
off-label use in two centres with an enthusiasm for this
device which should be used with caution as it still lacks
formal approval for use in EVAR. The fact that ProstarXL
was the first device developed and used earlier in the
learning curve for P-EVAR may also account for the
difference in results.
Several authors reported on device malfunction and
faulty puncture as a cause of failure and complications
particularly early in the experience (learning curve).24,25
High puncture site is usually associated with haemor-
rhage on mobilisation due to incorporating fibres of the
inguinal ligament into the suture, and a low puncture can
lead to ischaemia from vessel damage and occlusion. Pre-
procedural angiography through micropuncture sets can be
used to confirm correct puncture site.26 More recently,
intraoperative ultrasound guided puncture was found to
significantly improve the success rate and reduce P-EVAR
access related complications19 and would be recom-
mended as routine in all cases. Adoption of such adjuncts
should be routine practice but more so in the initial
learning curve where failures and complications were
reported by several authors.16,35 Femoral compression
devices have been used following percutaneous closure,
but evidence is lacking to whether this offers added
benifit.28 What this may do is cloud the issue of which
modality is being evaluated, the percutaneous device or
the use of compression devices.
The additional cost of percutaneous closure devices
and reimbursement issues are still considered obstacles
preventing these devices from widespread use. However,
there is a trend in reduction of operative time and
hospital stay with the use of percutaneous closure
devices. No further statistical analysis could be performed
here from the available data but several articles reported
individually a significant difference. It appears that this
will shift the cost effectiveness ratio to P-EVAR particu-
larly when a larger number of patients are treated with
this modality.
In conclusion, P-EVAR appears safe and effective in
selected patients. Local access related complications were
comparable to the best O-EVAR series. More work is
required to identify the most suitable candidates. A rand-
omised controlled trial including data on overall cost
effectiveness as well as outcome data is needed now to
define the role of P-EVAR in the contemporary management
of AAA.
Percutaneous Access for Endovascular Aneurysm Repair 681Funding
Unfunded.
Conflict of Interest
None.
Ethical approval
N/A.
References
1 Birch SE, Borchard KL, Hewitt PM, Stary D, Scott AR. Endovas-
cular abdominal aortic aneurysm repair: a 7 year experience at
the Launceston General Hospital. ANZ J Surg 2005;75(5):302e7.
2 Dalainas I, Nano G, Casana R, Tealdi Dg D. Mid-term results after
endovascular repair of abdominal aortic aneurysms: a four-year
experience. Eur J Vasc Endovasc Surg 2004;27(3):319e23.
3 Kibbe MR, Matsumura JS. The gore excluder US multi-center
trial: analysis of adverse events at 2 years. Semin Vasc Surg
2003;16(2):144e50.
4 Slappy AL, Hakaim AG, Oldenburg WA, Paz-Fumagalli R,
McKinney JM. Femoral incision morbidity following endovas-
cular aortic aneurysm repair. Vasc Endovascular Surg 2003;
37(2):105e9.
5 Faries PL, Brener BJ, Connelly TL, Katzen BT, Briggs VL,
Burks Jr JA, et al. A multicenter experience with the Talent
endovascular graft for the treatment of abdominal aortic
aneurysms. J Vasc Surg 2002;35(6):1123e8.
6 Cohnert TU, Oelert F, Wahlers T, Gohrbandt B, Chavan A,
Farber A, et al. Matched-pair analysis of conventional versus
endoluminal AAA treatment outcomes during the initial phase
of an aortic endografting program. J Endovasc Ther 2000;7(2):
94e100.
7 Moore WS, Kashyap VS, Vescera CL, Quinones-Baldrich WJ.
Abdominal aortic aneurysm: a 6-year comparison of endovas-
cular versus transabdominal repair. Ann Surg 1999;230(3):298e
306. discussion 306e298.
8 Chuter TA, Gordon RL, Reilly LM, Kerlan RK, Sawhney R, Jean-
Claude J, et al. Abdominal aortic aneurysm in high-risk
patients: short- to intermediate-term results of endovascular
repair. Radiology 1999;210(2):361e5.
9 Treharne GD, Thompson MM, Whiteley MS, Bell PR. Physiological
comparison of open and endovascular aneurysm repair. Br J
Surg 1999;86(6):760e4.
10 May J, White GH, Yu W, Ly CN, Waugh R, Stephen MS, et al.
Concurrent comparison of endoluminal versus open repair in the
treatment of abdominal aortic aneurysms: analysis of 303
patients by life table method. J Vasc Surg 1998;27(2):213e20.
discussion 220e211.
11 Brewster DC, Geller SC, Kaufman JA, Cambria RP, Gertler JP,
LaMuraglia GM, et al. Initial experience with endovascular
aneurysm repair: comparison of early results with outcome of
conventional open repair. J Vasc Surg 1998;27(6):992e1003.
discussion 1004e1005.
12 Stelter W, Umscheid T, Ziegler P. Three-year experience with
modular stent-graft devices for endovascular AAA treatment. J
Endovasc Surg 1997;4(4):362e9.
13 Blum U, Voshage G, Lammer J, Beyersdorf F, Tollner D,
Kretschmer G, et al. Endoluminal stent-grafts for infrarenal
abdominal aortic aneurysms. N Engl J Med 1997;336(1):13e20.
14 Larzon T, Geijer H, Gruber G, Popek R, Norgren L. Fascia
suturing of large access sites after endovascular treatment ofaortic aneurysms and dissections. J Endovasc Ther 2006;13(2):
152e7.
15 Diethrich EB. What do we need to know to achieve durable
endoluminal abdominal aortic aneurysm repair? Tex Heart Inst J
1997;24(3):179e84.
16 Traul DK, Clair DG, Gray B, O’Hara PJ, Ouriel K. Percutaneous
endovascular repair of infrarenal abdominal aortic aneurysms:
a feasibility study. J Vasc Surg 2000;32(4):770e6.
17 Lee WA, Brown MP, Nelson PR, Huber TS, Seeger JM. Midterm
outcomes of femoral arteries after percutaneous endovascular
aortic repair using the Preclose technique. J Vasc Surg 2008;
47(5):919e23.
18 Dosluoglu HH, Cherr GS, Harris LM, Dryjski ML. Total percutaneous
endovascular repair of abdominal aortic aneurysms using Perclose
ProGlide closure devices. J Endovasc Ther 2007;14(2):184e8.
19 Arthurs ZM, Starnes BW, Sohn VY, Singh N, Andersen CA.
Ultrasound-guided access improves rate of access-related
complications for totally percutaneous aortic aneurysm repair.
Ann Vasc Surg 2008;22(6):736e41.
20 Quinn SF, Kim J. Percutaneous femoral closure following stent-
graft placement: use of the Perclose device. Cardiovasc Inter-
vent Radiol 2004;27(3):231e6.
21 Lee WA, Brown MP, Nelson PR, Huber TS. Total percutaneous
access for endovascular aortic aneurysm repair (‘‘Preclose’’
technique). J Vasc Surg 2007;45(6):1095e101.
22 Heyer KS, Resnick SA, Matsumura JS, Amaranto D, Eskandari MK.
Percutaneous Zenith endografting for abdominal aortic aneu-
rysms. Ann Vasc Surg 2009;23(2):167e71.
23 Najjar SF, Mueller KH, Ujiki MB, Morasch MD, Matsumura JS,
Eskandari MK. Percutaneous endovascular repair of ruptured
abdominal aortic aneurysms. Arch Surg 2007;142(11):1049e52.
24 Jean-Baptiste E, Hassen-Khodja R, Haudebourg P, Bouillanne PJ,
Declemy S, Batt M. Percutaneous closure devices for endovas-
cular repair of infrarenal abdominal aortic aneurysms:
a prospective, non-randomized comparative study. Eur J Vasc
Endovasc Surg 2008;35(4):422e8.
25 Watelet J, Gallot JC, Thomas P, Douvrin F, Plissonnier D.
Percutaneous repair of aortic aneurysms: a prospective study of
suture-mediated closure devices. Eur J Vasc Endovasc Surg
2006;32(3):261e5.
26 Starnes BW, Andersen CA, Ronsivalle JA, Stockmaster NR,
Mullenix PS, Statler JD. Totally percutaneous aortic aneurysm
repair: experience and prudence. J Vasc Surg 2006;43(2):270e6.
27 Peterson BG, Matsumura JS, Morasch MD, West MA,
Eskandari MK. Percutaneous endovascular repair of blunt
thoracic aortic transection. J Trauma 2005;59(5):1062e5.
28 Borner G, Ivancev K, Sonesson B, Lindblad B, Griffin D, Malina M.
Percutaneous AAA repair: is it safe? J Endovasc Ther 2004;11(6):
621e6.
29 Torsello GB, Kasprzak B, Klenk E, Tessarek J, Osada N,
Torsello GF. Endovascular suture versus cutdown for endovas-
cular aneurysm repair: a prospective randomized pilot study. J
Vasc Surg 2003;38(1):78e82.
30 Howell M, Doughtery K, Strickman N, Krajcer Z. Percutaneous
repair of abdominal aortic aneurysms using the AneuRx stent
graft and the percutaneous vascular surgery device [see
comment]. Catheter Cardiovasc Interv 2002;55(3):281e7.
31 Quinn SF, Duke DJ, Baldwin SS, Bascom TH, Ruff SJ,
Swangard RJ, et al. Percutaneous placement of a low-profile
stent-graft device for aortic dissections. J Vasc Interv Radiol
2002;13(8):791e8.
32 Teh LG, Sieunarine K, van Schie G, Goodman MA, Lawrence-
Brown M, Prendergast FJ, et al. Use of the percutaneous
vascular surgery device for closure of femoral access sites
during endovascular aneurysm repair: lessons from our experi-
ence. Eur J Vasc Endovasc Surg 2001;22(5):418e23.
33 McDonnell CO, Forlee MV, Dowdall JF, Colgan MP, Madhavan P,
Shanik GD, et al. Percutaneous endovascular abdominal aortic
682 A.H. Malkawi et al.aneurysm repair leads to a reduction in wound complications. Ir
J Med Sci 2008;177(1):49e52.
34 Morasch MD, Kibbe MR, Evans ME, Meadows WS, Eskandari MK,
Matsumura JS, et al. Percutaneous repair of abdominal aortic
aneurysm. J Vasc Surg 2004;40(1):12e6.
35 Howell M, Villareal R, Krajcer Z. Percutaneous access and
closure of femoral artery access sites associated with endolu-
minal repair of abdominal aortic aneurysms. J Endovasc Ther
2001;8(1):68e74.36 Rachel ES, Bergamini TM, Kinney EV, Jung MT, Kaebnick HW,
Mitchell RA. Percutaneous endovascular abdominal aortic
aneurysm repair. Ann Vasc Surg 2002;16(1):43e9.
37 Haas PC, Krajcer Z, Diethrich EB. Closure of large percutaneous
access sites using the Prostar XL Percutaneous Vascular Surgery
device. J Endovasc Surg 1999;6(2):168e70.
38 Johanning JM, Franklin DP, Elmore JR, Han DC. Femoral artery
infections associated with percutaneous arterial closure
devices. J Vasc Surg 2001;34(6):983e5.
